Several studies have shown that breast cancer patients with PIK3CA mutations have a better prognosis 30, 31, while Sobhani et al. reported a significantly worse prognosis for women with PIK3CA-mutant breast tumors 32. This evidence concerns the gene PIK3CA and breast cancer.